Envestnet Asset Management
EGRX

Envestnet Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Envestnet Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,971
Closed -$406K – 4088
2021
Q4 		$406K Sell
7,971
-890
-10% -$46.1K ﹤0.01% 3200
2021
Q3 		$494K Buy
8,861
+462
+6% +$22.7K ﹤0.01% 2968
2021
Q2 		$359K Sell
8,399
-1,415
-14% -$58.4K ﹤0.01% 3179
2021
Q1 		$410K Buy
9,814
+142
+1% +$6.59K ﹤0.01% 2959
2020
Q4 		$450K Sell
9,672
-761
-7% -$35.6K ﹤0.01% 2711
2020
Q3 		$443K Sell
10,433
-228
-2% -$9.97K ﹤0.01% 2528
2020
Q2 		$512K Sell
10,661
-266
-2% -$13.3K ﹤0.01% 2412
2020
Q1 		$503K Buy
10,927
+469
+4% +$23.5K ﹤0.01% 2228
2019
Q4 		$628K Sell
10,458
-669
-6% -$39.9K ﹤0.01% 2314
2019
Q3 		$629K Buy
11,127
+1,300
+13% +$73.1K ﹤0.01% 2234
2019
Q2 		$547K Buy
9,827
+2,016
+26% +$105K ﹤0.01% 2347
2019
Q1 		$394K Buy
7,811
+1,431
+22% +$63.7K ﹤0.01% 2480
2018
Q4 		$257K Buy
+6,380
New +$329K ﹤0.01% 2519

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Envestnet Asset Management's EGRX Position: Q1 2022 in Review

Envestnet Asset Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2022, closing a stake of 7,971 shares — an estimated $406K sold.

Envestnet Asset Management first reported a position in EGRX in Q4 2018 and held it in 13 quarters. The position peaked at $629K in Q3 2019. 160 funds tracked by Wall St. Rank hold EGRX as of Q1 2022.

  • Envestnet Asset Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 7,971 Eagle Pharmaceuticals, Inc. shares in Q1 2022, an estimated $406K.
  • Envestnet Asset Management first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2018 and held it in 13 quarters.
  • Envestnet Asset Management's Eagle Pharmaceuticals, Inc. position peaked at $629K in Q3 2019.
  • 160 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2022.

Based on Envestnet Asset Management's 13F filing for Q1 2022, filed 4 May 2022.